American Journal of Medicine and Medical Sciences

p-ISSN: 2165-901X    e-ISSN: 2165-9036

2022;  12(5): 451-454

doi:10.5923/j.ajmms.20221205.01

Received: April 21, 2022; Accepted: May 8, 2022; Published: May 10, 2022

 

Estrogen (ER-α) and Progesterone (PR-α) Receptors Expression in Egg Endometriosis

Israilov Rajab Israilovich1, Juraeva Gulbakhor Baxshillaevna2

1Director of the Republican Pathological Anatomical Center, Tashkent, Uzbekistan

2Candidate of Medical Sciences, Head of the Department of Pathological Anatomy, Bukhara, Uzbekistan

Correspondence to: Juraeva Gulbakhor Baxshillaevna, Candidate of Medical Sciences, Head of the Department of Pathological Anatomy, Bukhara, Uzbekistan.

Email:

Copyright © 2022 The Author(s). Published by Scientific & Academic Publishing.

This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/

Abstract

This paper examines the degree of expression of estrogen (ER-α) and progesterone (PR-α) receptors in both glandular epithelium and stromal structures in ovarian endometriosis. As a material, ovarian tissue from 28 patients was immunohistochemically examined. Immunohistochemical examination of ovarian endometriosis revealed differences in the expression of estrogen (ER-α) and progesterone (PR-α) receptors in both epithelial cells and stromal structures. The sensitivity of these tissue structures to hormones during endometriosis, and the formation of specific protein receptors indicates the high rate of expression of the ER-α receptor relative to the PR-α receptor in epithelial cells that have become endometriotic glands relative to stroma structures indicates that the role of the hormone estrogen in the mechanism of endometriosis development is highly important.

Keywords: Ovary, Endometriosis, Immunohistochemistry, Estrogen, Progesterone, ER-a, PR-a receptors

Cite this paper: Israilov Rajab Israilovich, Juraeva Gulbakhor Baxshillaevna, Estrogen (ER-α) and Progesterone (PR-α) Receptors Expression in Egg Endometriosis, American Journal of Medicine and Medical Sciences, Vol. 12 No. 5, 2022, pp. 451-454. doi: 10.5923/j.ajmms.20221205.01.

1. Introduction

In the study of endometriosis by morphological, histochemical, and immunohistochemical methods, it is important to know the histogenesis of the origin of the endometrial glands and epithelial glands of organs and tissues where endometriosis develops. After all, the metaplastic theory of the development of endometriosis plays a key role. The ovarian and Mueller tubes of the ovary arise from the selemic mesothelium, so the germinative epithelium of the ovary becomes the endometrial glands. However, because the mesothelium of the peritoneal serous membrane is a multipotent tissue, abdominal endometriosis develops from in-situ metaplasia of the mesothelium [1,2].
In the study of the pathogenesis of endometriosis, Sampson advanced the theory of implantation. Because menstrual blood contains endometrial cells, they are implanted in the abdomen and other organs, proliferate, and lead to endometriosis. Hence, retrograde shortening of the fallopian tube causes retrograde menstruation and is a confirmation of the development of endometriosis in the fallopian tube and abdominal cavity [3,4,5]. It is estimated that the dissemination of endometrial cells through lymph and blood vessels causes extragenital forms of endometriosis.
Sex hormones play a key role in the pathogenesis of endometriosis. Several clinical and experimental studies have confirmed that endometriosis is an estrogen-dependent disease. As evidence of this, endometriosis does not develop in girls until menopause begins. Endometriosis is often confirmed to develop due to high levels of estrogen, estrogenic obesity, and the artificial introduction of estrogen medication.
Immunohistochemical examination detects protein-type receptors located on the surface of estrogen and progesterone-sensitive cells, i.e., antigen-specific antibodies. Because the epithelium of other organs and tissues outside the uterus originates from the selemic epithelium, receptors sensitive to specific estrogen and progesterone hormones appear, affecting them as the number of sex hormones in the body increases [3,4]. Detection of these receptors by antigen-antibody reaction in the immunohistochemical examination, their positive staining with a specially marked antibody confirms the presence of these receptors, the development of endometriosis. The results of this immunohistochemical method are evaluated by the following accepted terms: "strong positive reaction", "false positive reaction", "negative reaction" and "false negative reaction".

2. Materials and Methods

As a material, a total of 28 patients with an average age of 28.5 ± 4.2 years who underwent surgery in the RPAС of the Republic of Uzbekistan biopsy diagnostics department in 2016-2021 underwent macroscopic examination of ovaries surgically removed with a diagnosis of endometriosis and incisions were made from areas where endometriosis-specific glands and cysts had grown. Biopsy sections were incubated for 48h in 10% neutralized formalin. Dehydration was carried out at increasing concentrations of alcohols and chloroform. Histological incisions were initially stained with hematoxylin and eosin to determine topography. Then a series of cuts from paraffin bricks were carried out in a specially automated system Ventana Benchmark XT, Roche, Switzerland, deparaffinization, dehydration, demasking, and staining in antigens. Receptors sensitive to estrogen (ER-α) and progesterone (PR-α) were identified using specially labeled antibodies. These receptors for weak, moderate, and strongly positively stained glandular epithelium and stromal cells were calculated by the following formula: HS = 1a + 2b + 3c, where a is the percentage of weakly stained cells, b is the percentage of moderately stained cells, and s is the percentage of strongly stained cells. The results were calculated on the following points: 0-10 points - no expression, 11 - 80 points - slow expression, 81 - 140 points - average expression, 141 - 300 points - strong expression. Statistical analysis of the obtained quantitative indicators is a practical statistical analysis program (Statistica Windows 10.0, SPSS Statistics 22, Microsoft Excel). In the groups, the performance of the characters was assessed using the Manna-Whitney test, and the statistical evaluation of the characters was performed at p≤0.05.

3. Results and Discussion

The results of the study were determined as a percentage of slow, moderate, and high levels of estrogen (ER-α) and progesterone (PR-α) receptor expression. Estrogen (ER-α) receptor expression in the ovarian glandular epithelium was strong in 72.6% of 28 patients - an average of 286.4 points, 19.2% - 138.6 points, and 8.2% - 56.8 points. expressed. In cases of strong expression of the estrogen (ER-a) receptor, the epithelium of endometriotic gland structures growing under the outer mesothelium of the ovary is located in 2-3 rows, and both the cytoplasm and the nucleus of the ER-a receptor are strongly brown (Fig. 1). In the single-layered prismatic epithelium covering the outer surface of the ovary, it is observed that this receptor is almost not expressed. ER-α receptors are also relatively well expressed in the cells of the stroma-vascular structures around the gland.
Figure 1. Strong expression of the ER-α receptor in ovarian endometriotic glands. Stain: immunohistochemical method. X400
In 8.2% of cases of ovarian endometriosis, the epithelium of endometriotic glandular structures consists mainly of single-layered prismatic and cylindrical epithelium, and in their cytoplasm, the ER-a receptor is expressed in a slightly light brown form (Fig. 2). In the epithelial nuclei of some of these glands, this receptor is found to be relatively well expressed. It is also found that this receptor is less expressed in the stroma cells around the glands than in the previous group of patients.
Figure 2. Slow expression of the ER-α receptor in ovarian endometriosis glands. Stain: immunohistochemical method. X400
In cases of ovarian endometriosis, the level of estrogen (ER-a) receptor expression in the cells of stroma-vascular structures was also different, i.e. strong expression in 56.8% (264.8 points), moderate expression in 28.7% (134.6 points) and slow expression in 14.5% (48.6 points). Studies of ovarian stroma structures have shown that the ER-α receptor is well expressed in the cytoplasm of most histiocytic cells, as well as in the nuclei of some. Most of the histiocytic cells are large, and in their cytoplasm, it is found that this receptor is expressed in the form of granules of various sizes from dark brown to light golden (Fig. 3). Depending on the degree of maturation of the cells, i.e. in less differentiated histiocytic cells, it is observed that this receptor is less expressed. In some very small and lymphoid-like structures, it is found to be in the form of light golden granules resembling tiny bubbles.
Figure 3. Ovarian endometriosis, good expression of ER-α receptor in stroma cells. Stain: immunohistochemistry. X450
Figure 4. Ovarian endometriosis, slow expression of the ER-α receptor in stroma cells. Stain: immunohistochemistry. X650
Determination of the degree of expression of the progesterone (PR-a) receptor in ovarian endometriosis showed that this receptor was also expressed at different levels in the glandular cells and stroma structures. Progesterone (PR-a) receptor expression in the ovarian glandular epithelium was strong in 62.6% of 28 patients - an average of 262.4 points, 25.3% - 128.2 points and 12.1% - 36.8 points expressed. Morphologically, the expression of the progesterone (PR-a) receptor has specific characteristics. When this receptor was strongly expressed in the glandular epithelium, it was observed that the nuclei of the cell were mostly stained dark brown (Fig. 5). Another peculiarity was that this receptor was found to be expressed only in stromal cells around the glands. Low expression of this receptor was observed at some relatively strong levels of glandular epithelium and very low levels at others (Fig. 6). In the stromal structures surrounding such glands, however, expression was not observed only in individual cells and in most histiocytic cells.
Figure 5. Ovarian endometriosis, expression of progesterone (PR-a) receptors in both epithelial and stromal cells. Stain: immunohistochemistry. X400
Figure 6. Ovarian endometriosis, expression of progesterone (PR-a) receptors in both epithelial and stromal cells. Stain: immunohistochemistry. X400

4. Conclusions

Immunohistochemically examination of ovarian endometriosis revealed differences in the expression of estrogen (ER-α) and progesterone (PR-α) receptors in both epithelial cells and stromal structures. The sensitivity of these tissue structures to hormones during endometriosis, and the formation of specific protein receptors indicates the high rate of expression of the ER-α receptor relative to the PR-α receptor in epithelial cells that have become endometriosis glands relative to the stroma structures indicates that the role of the hormone estrogen in the mechanism of endometriosis development is highly important. A deeper study of the composition of these receptors at the level of molecular biology will help to determine what macromolecular reactions underlie the pathogenesis of endometriosis.

References

[1]  Pshenichnyuk E.Yu., Asaturova A.V., Adamyan L.V., Zaitsev N.V. Immunohistochemical predictors of recurrence of endometrioid ovarian cysts after laparoscopic surgical treatment. Archive of pathology. 2018; 80(4): 14 20.
[2]  Storey D.J. et al. Endometrioid epithelial ovarian cancer: 20 years of prospectively collected data from a single center // Cancer. 2008. Vol. 112, № 10. pp. 2211-2220.
[3]  Rambau P.F. et al. Significant frequency of MSH2 / MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas // Histopathology. 2016. Vol. 69, № 2. pp. 288-297.
[4]  Kaspar H.G., Crum C.P. The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders // Arch. Pathol. Lab. Med. 2015. Vol. 139, № 1. pp. 39-54.
[5]  Rambau P.F. et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary // Am.J. Surg. Pathol. 2017. Vol. 41, № 5. pp. 685-695.7.
[6]  Olive DL, Schwartz LB. Endometriosis. N Engl J Med. 1993; 328(24): 1759–1769.
[7]  Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006; 248(1–2): 94–103.
[8]  Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993; 60(1): 75–79.
[9]  Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril. 1996; 65(2): 299–304.
[10]  Lin Z, Reierstad S, Huang CC, Bulun SE. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res. 2007; 67(10): 5017–5024.
[11]  Matthews J, Wihlén B, Tujague M, Wan J, Ström A, Gustafsson JA. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol. 2006; 20(3): 534–543.
[12]  Teh WT, McBain J, Rogers P. What is the contribution of embryo-endometrial asynchrony to implantation failure? J Assist Reprod Genet. 2016; 33: 1419–1430.
[13]  Sharma A, Kumar P. Understanding implantation window, a crucial phenomenon. J Hum Reprod Sci. 2012; 5: 2–6.
[14]  Fox C, Lessey BA. Signaling between embryo and endometrium: Normal implantation. In: Recurrent Implantation Failure: Etiologies and Clinical Management, pp1-19, 2018.
[15]  Young SL. Oestrogen and progesterone action on endometrium: A translational approach to understanding endometrial receptivity. Reprod Biomed Online. 2013; 27: 497–505.